USPTO serial 85555680
GO IN VIVO
Reviewed by CopyMark Law Group
Reg. 4859983Status 710
- Filing date
- Status date
- Registration date
- Nov 24, 2015
- Examiner
- MAI, TINA HSIN
- Law office
- TMEG LAW OFFICE 108
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GO IN VIVO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BERKELEY, CA, US
Berkeley, CA, US
BERKELEY, CA, US
BERKELEY, CA, US
Berkeley, CA, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Assays and reagents for use in genetic research; Assays for research purposes; Biochemicals, namely, precursors for in vitro genetic engineering use; Genetic identity tests comprised of reagents ] [ ; Paternity identity tests comprised of reagents ] | SECTION 8 - CANCELLED | Mar 1, 2015 |
| 009 | Computer software for scientific analysis of genetic sequences; Electrical equipment for the genetic modification of cells for research purposes; Laboratory devices for detecting genetic sequences | SECTION 8 - CANCELLED | Mar 1, 2015 |
| 010 | [ Light-based medical devices, namely, a light emitting diode (LED) device for increasing the human body's own production of collagen; Medical apparatus for treating congestive heart failure; Medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tract; Medical device for accessing subcutaneous structures of the human body for the purpose of administering medical treatment; Medical device for detecting cancer; Medical device for treating cancer; Medical device for treating lymphedema; Medical device, namely, a device for improving cardiac performance through aortic flow therapy; Medical device, namely, a device for measuring arterial blood flow in the eye; Medical device, namely, a remote manipulation system consisting of a robotic arm, knob, deflection lever, and buttons, to facilitate remote catheterizations; Medical device, namely, a tele-robotic system consisting of a motorized catheter positioner having rotational and translational movement capability and a tele-robotic controller with rotation, translation and deflection control buttons, to facilitate remote catheterizations; Medical devices and apparatus, namely, ultrasound imaging apparatus, scanners and needle guides, and parts and fittings therefor; Medical devices, namely, devices for spinal disc repair in the nature of an apparatus used in spinal disc repair procedures; Medical devices, namely, devices for spinal disc repair in the nature of spinal disc implants made from artificial substances; Medical devices, namely, hand-held motorized, vibrating devices used near injection sites for reducing pain during hypodermic needle injections; Medical devices, namely, intravascular implants comprised of artificial material; Medical devices, namely, minimally invasive devices for abdominal aortic aneurysms repair; Medical devices, namely, minimally invasive neurovascular devices for the treatment of neurological conditions; Medical devices, namely, myocardial ischemia scanning devices; Medical devices, namely, surgical devices that facilitate the identification, separation or ablation of biologic tissues ] | SECTION 8 - CANCELLED | Mar 1, 2015 |
| 042 | Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Genetic mapping for scientific purposes; Genetic testing of laboratory animals for research purposes; [ Providing a website featuring information about investigational medical devices, diagnostic and drugs; ] Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research in the field of genetics and genetic engineering; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy | SECTION 8 - CANCELLED | Mar 1, 2015 |
| 044 | Genetic testing for medical purposes; Genetic testing of animals | SECTION 8 - CANCELLED | Mar 1, 2015 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SPIRAL DEVICES, LLC
- Other trademarks owned by Spiral Genomics, LLC
- Other trademarks owned by SPIRAL DEVICES, LLC
- Other trademarks owned by BAY GENOMICS, LLC
- Other trademarks owned by Spiral Genomics, LLC
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GO IN VIVO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 5, 2026 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Nov 24, 2024 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Nov 18, 2022 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Nov 18, 2022 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 17, 2022 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| May 17, 2022 | PR23 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 | — |
| May 17, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 24, 2021 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 24, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 3, 2016 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 24, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 17, 2015 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 16, 2015 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 16, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 16, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 16, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 16, 2015 | SNEA | SU-EXAMINER'S AMENDMENT WRITTEN | — |
| Mar 20, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2015 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2015 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 12, 2015 | IUAF | USE AMENDMENT FILED | — |
| Mar 12, 2015 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 4, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 3, 2014 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 1, 2014 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 1, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 8, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 7, 2014 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 1, 2014 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 1, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 5, 2013 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 2, 2013 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 28, 2013 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 2, 2013 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 1, 2013 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 1, 2013 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 1, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 2, 2013 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 5, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 5, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 16, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 29, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 24, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 19, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 19, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2012 | ALIE | ASSIGNED TO LIE | — |
| Dec 8, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 8, 2012 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 8, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 7, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 2, 2012 | NWAP | NEW APPLICATION ENTERED | — |